These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

203 related articles for article (PubMed ID: 16948845)

  • 1. Circulating viral core and E1 antigen levels as supplemental markers for HCV chronic hepatitis.
    El Awady MK; El Abd YS; Shoeb HA; Tabll AA; Hosny Ael D; El Shenawy RM; Atef K; Bader El Din NG; Bahgat MM
    Virol J; 2006 Sep; 3():67. PubMed ID: 16948845
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Evaluation of a total hepatitis C virus (HCV) core antigen assay for the detection of antigenaemia in anti-HCV positive individuals.
    Valcavi P; Medici MC; Casula F; Arcangeletti MC; De Conto F; Pinardi F; Calderaro A; Chezzi C; Dettori G
    J Med Virol; 2004 Jul; 73(3):397-403. PubMed ID: 15170635
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Evaluation of a total core antigen assay for the diagnosis of hepatitis C virus infection in hemodialysis patients.
    Bouzgarrou N; Fodha I; Othman SB; Achour A; Grattard F; Trabelsi A; Pozzetto B
    J Med Virol; 2005 Dec; 77(4):502-8. PubMed ID: 16254976
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Performance of two Real-Time RT-PCR assays for quantitation of hepatitis C virus RNA: evaluation on HCV genotypes 1-4.
    Elkady A; Tanaka Y; Kurbanov F; Sugauchi F; Sugiyama M; Khan A; Ali EM; Mouhamed L; Abou el-fetouh S; AbdEl-Hameed AR; Mizokami M
    J Med Virol; 2010 Nov; 82(11):1878-88. PubMed ID: 20872714
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Expression of the full-length HCV core subgenome from HCV gentoype-1a and genotype-3a and evaluation of the antigenicity of translational products.
    Ansari MA; Irshad M; Agarwal SK; Chosdol K
    Eur J Gastroenterol Hepatol; 2013 Jul; 25(7):806-13. PubMed ID: 23442416
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Total HCV core antigen assay. A new marker of HCV viremia and its application during treatment of chronic hepatitis C.
    Lorenzo J; Castro A; Aguilera A; Prieto E; López-Calvo S; Regueiro B; Pedreira J
    J Virol Methods; 2004 Sep; 120(2):173-7. PubMed ID: 15288960
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Evaluation of a new enzyme immunoassay for hepatitis C virus (HCV) core antigen with clinical sensitivity approximating that of genomic amplification of HCV RNA.
    Tanaka E; Ohue C; Aoyagi K; Yamaguchi K; Yagi S; Kiyosawa K; Alter HJ
    Hepatology; 2000 Aug; 32(2):388-93. PubMed ID: 10915747
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Qualitative detection of hepatitis C virus core antigen in the serum in patients with chronic hepatitis C].
    Ouyang Y; Tan DM; Li TG; Zhou H; Tan C
    Zhong Nan Da Xue Xue Bao Yi Xue Ban; 2006 Dec; 31(6):894-6, 905. PubMed ID: 17213591
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Reliability of hepatitis C virus core antigen assay for detection of viremia in HCV genotypes 1, 2, 3, and 4 infected blood donors: a collaborative study between Japan, Egypt, and Uzbekistan.
    Agha S; Tanaka Y; Saudy N; Kurbanov F; Abo-Zeid M; El-Malky M; Khalaf M; Ohta N; Yoshizawa H; Mizokami M
    J Med Virol; 2004 Jun; 73(2):216-22. PubMed ID: 15122795
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Long-term evolution of serum and liver viral markers in patients treated for chronic hepatitis C and sustained response.
    Moreno M; Pérez-Alvarez R; Rodrigo L; Pérez-López R; Suárez-Leiva P
    J Viral Hepat; 2006 Jan; 13(1):28-33. PubMed ID: 16364079
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Diagnostic algorithm for chronic hepatitis C virus infection: role of the new HCV-core antigen assay.
    Tillmann HL; Wiegand J; Glomb I; Jelineck A; Picchio G; Wedemeyer H; Manns MP
    Z Gastroenterol; 2005 Jan; 43(1):11-6. PubMed ID: 15650966
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Profiles of HCV core protein and viremia in chronic hepatitis C: possible protective role of core antigen in liver damage.
    Carabaich A; Ruvoletto M; Bernardinello E; Tono N; Cavalletto L; Chemello L; Gatta A; Pontisso P
    J Med Virol; 2005 May; 76(1):55-60. PubMed ID: 15778969
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Association of antibodies to hepatitis C virus glycoproteins 1 and 2 (anti-E1E2) with HCV disease.
    Hamed MR; Tarr AW; McClure CP; Ball JK; Hickling TP; Irving WL
    J Viral Hepat; 2008 May; 15(5):339-45. PubMed ID: 18221305
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Performance and clinical utility of a novel fully automated quantitative HCV-core antigen assay.
    Mederacke I; Wedemeyer H; Ciesek S; Steinmann E; Raupach R; Wursthorn K; Manns MP; Tillmann HL
    J Clin Virol; 2009 Nov; 46(3):210-5. PubMed ID: 19766055
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Clinical utility of total HCV core antigen quantification: a new indirect marker of HCV replication.
    Bouvier-Alias M; Patel K; Dahari H; Beaucourt S; Larderie P; Blatt L; Hezode C; Picchio G; Dhumeaux D; Neumann AU; McHutchison JG; Pawlotsky JM
    Hepatology; 2002 Jul; 36(1):211-8. PubMed ID: 12085367
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Quantitative antibody responses to structural (Core) and nonstructural (NS3, NS4, and NS5) hepatitis C virus proteins among seroconverting injecting drug users: impact of epitope variation and relationship to detection of HCV RNA in blood.
    Beld M; Penning M; van Putten M; Lukashov V; van den Hoek A; McMorrow M; Goudsmit J
    Hepatology; 1999 Apr; 29(4):1288-98. PubMed ID: 10094977
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Clinical utility of hepatitis C virus core antigen quantification in patients with chronic hepatitis C.
    Chevaliez S; Soulier A; Poiteau L; Bouvier-Alias M; Pawlotsky JM
    J Clin Virol; 2014 Sep; 61(1):145-8. PubMed ID: 24973282
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Hepatitis C virus infection in dialysis and chronic liver patients: Viraemia dependent anti-E2-antibody response.
    Hanuka N; Sikuler E; Tovbin D; Neville L; Nussbaum O; Mostoslavsky M; Orgel M; Yaari A; Manor S; Dagan S; Hilzenrat N; Shemer-Avni Y
    J Med Virol; 2004 Aug; 73(4):529-35. PubMed ID: 15221896
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Hepatitis C virus core antigen: analytical performances, correlation with viremia and potential applications of a quantitative, automated immunoassay.
    Medici MC; Furlini G; Rodella A; Fuertes A; Monachetti A; Calderaro A; Galli S; Terlenghi L; Olivares M; Bagnarelli P; Costantini A; De Conto F; Sainz M; Galli C; Manca N; Landini MP; Dettori G; Chezzi C
    J Clin Virol; 2011 Aug; 51(4):264-9. PubMed ID: 21621454
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Is an assay for simultaneous detection of hepatitis C virus core antigen and antibody a valuable alternative to nucleic acid testing?
    Laperche S; Elghouzzi MH; Morel P; Asso-Bonnet M; Le Marrec N; Girault A; Servant-Delmas A; Bouchardeau F; Deschaseaux M; Piquet Y
    Transfusion; 2005 Dec; 45(12):1965-72. PubMed ID: 16371051
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.